FEATURED EDITORIAL
The Pistoia Alliance conducted a survey as a pulse check on which technologies the pharma/biotech industry is investing in and companies' progress integrating new tech into the lab.
- How To Overcome Immune Rejection In iPSC-based Gene Therapy
- Emerging Partnership Trends In Oligo-Based Medicines
- Exploring Sanofi R&D's Batch Monitoring Initiative
- Panavance Details IND Prep Ahead Of FDA Submission For Ovarian Cancer Trial
- iPSC-based Gene Therapy: Applications And Challenges
- Restoring Immune Homeostasis As A Development Approach To Treat And Modify Inflammatory Disease
- Keys To Successful CMC Source Document Preparation For Cell & Gene Therapies
FEATURED APPLICATION CONTENT
-
Sartoclear® depth filters deliver high performance for adeno-associated virus (AAV) clarification, ensuring scalability, high recovery rates, and robust filtration.
-
Emergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.
-
This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.
-
Here, we discuss the challenges and solutions for cell and gene therapies, focusing on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access.
-
Discover a system that automates mAb purification, reducing time and costs in cell line development while improving reproducibility, with faster processing than traditional methods.
-
Discover a combination that enables efficient clone selection and automated purification, improving bioprocessing speed, and accelerating biotherapeutic development.
-
This study evaluates a cost-effective alternative to Proleukin® for expanding T cells that demonstrates comparable performance across cell viability, subpopulation ratios, and clinical consistency.
-
Explore two innovative technologies that address major purification challenges in DSP: continuous multi-column chromatography and advanced chromatography or liquid chromatography-mass spectrometry.
-
Issues related to cleaning and cleaning validation are some of the most common concerns that arise in FDA Warning Letters. Discover how to ensure you pass your cleaning validation tests.
-
Discover the innovative methods behind CAR-T cell production, from custom plasmid design to lentiviral vector transduction, and explore their potential in revolutionizing cancer treatment.
-
Explore the results of a study focusing on the early stages of the CAR T cell workflow, specifically the initial washing of leukapheresis followed by the isolation of T cells.
-
Discover how you can achieve a final mAb concentration above 200 g/L while maintaining critical quality attributes.
FEATURED NEWS HEADLINES
- XtalPi Leverages AWS To Enhance Drug Discovery
- Novel All-In-One Computational Pipeline Identifies Protein Biomarkers Associated With Alzheimer's Disease And Predicts 3D Structural Alterations
- Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Second Fast Track Designation From FDA For Treatment Of Triple Negative Breast Cancer (TNBC)
- Beckman Coulter Life Sciences Accelerates Drug Discovery With Launch Of Cydem VT Automated Clone Screening System
- Duality Biologics And GSK Enter Exclusive Option Agreement For A Novel Antibody-Drug Conjugate (DB-1324)
- Congruence And Ono Announce Multi-Target Research Collaboration To Generate Small Molecule Correctors For The Treatment Of Cancer
- Saol Therapeutics Announces Submission Of New Drug Application (NDA) To The U.S. FDA For SL1009
- SoftServe Unveils New Gen AI Solution 'Drug Discovery,' Built With NVIDIA Blueprints At AWS Re:Invent 2024
- Cytokinetics Announces FDA Acceptance Of New Drug Application For Aficamten For The Treatment Of Obstructive Hypertrophic Cardiomyopathy
- Breakthrough 3D Printing Technology Could Bring End Of Animal Drug Testing A Step Closer
ARCHIVED NEWSLETTER
- 12.03.24 -- How To Overcome Immune Rejection In iPSC-based Gene Therapy
- 12.02.24 -- Streamline Your Oral Drug Development Process
- 11.27.24 -- Find The Perfect CDMO Partner For Your Project
- 11.26.24 -- Emerging Partnership Trends In Oligo-Based Medicines
- 11.25.24 -- Choosing The Ideal CDMO Partner For Your Project